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2014; Hinshaw and Harrison, 2018). Kinetochore structure 
changes dramatically across the cell cycle from a ball of con-
densed chromatin containing the specialized histone H3 subtype 
CENP-A during interphase (Brenner et al., 1981; Moroi et al., 
1981; Earnshaw et al., 1985; Shang et al., 2013) to a trilaminar 
plate during mitosis (Roos, 1973). To fully understand kinetochore 
maturation, we need not only a complete parts list, but also a 
dynamic map of protein neighborhoods during this remarkable 
structural transformation.
Following the initial discoveries of centromere proteins using 
autoantibodies (Moroi et al., 1980; Guldner et al., 1984; Earnshaw 
et al., 1985), characterization of the kinetochore proteome contin-
ued with the isolation of kinetochore subcomplexes using anti-
bodies to CENP-A (Ando et al., 2002) and tandem affinity tags 
(Cheeseman and Desai, 2005; Foltz et al., 2006; Hori et al., 2008). 
However, such affinity-purification methods are not well suited to 
identify either transient low-affinity protein–protein interactions or 
those that occur in the context of insoluble subcellular structures 
such as mitotic chromosomes or kinetochores. Traditional affinity-
purification methods all begin with solubilization of the target 
protein, a procedure that can disrupt important protein–protein 
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ABSTRACT The centromere is located at the primary constriction of condensed chromo-
somes where it acts as a platform regulating chromosome segregation. The histone H3 vari-
ant CENP-A is the foundation for kinetochore formation. CENP-A directs the formation of a 
highly dynamic molecular neighborhood whose temporal characterization during mitosis re-
mains a challenge due to limitations in available techniques. BioID is a method that exploits 
a “promiscuous” biotin ligase (BirA118R or BirA*) to identify proteins within close proximity 
to a fusion protein of interest. As originally described, cells expressing BirA* fusions were 
exposed to high biotin concentrations for 24 h during which the ligase transferred activated 
biotin (BioAmp) to other proteins within the immediate vicinity. The protein neighborhood 
could then be characterized by streptavidin-based purification and mass spectrometry. Here 
we describe a further development to this technique, allowing CENP-A interactors to be 
characterized within only a few minutes, in an in vitro reaction in lysed cells whose physiolog-
ical progression is “frozen.” This approach, termed in vitro BioID (ivBioID), has the potential 
to study the molecular neighborhood of any structural protein whose interactions change 
either during the cell cycle or in response to other changes in cell physiology.
INTRODUCTION
The kinetochore is a complex multiprotein machine that directs 
chromosome segregation at mitosis (Santaguida and Musacchio, 
2009; Ng et al., 2013; Westhorpe and Straight, 2013; Cheeseman, 
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interactions. This has been overcome, at least in part, by the 
development of methods such as EMARS (enzyme-mediated 
activation of radical sources; Kotani et al., 2008) and SPPLAT 
(selective proteomic proximity labeling assay using tyramide; 
Rees et al., 2015), allowing in situ proximity-based labeling of 
proteins in cells.
In EMARS horseradish peroxidase (HRP) is coupled to an anti-
body, protein ligand, or a fusion protein, for localization purposes at 
the plasma membrane. The labeling is performed using aryl azide-
biotin or aryl azide-fluorescein. When oxidized by HRP in the pres-
ence of H2O2, these substrates bind to proteins proximal to the lo-
calized HRP. SPPLAT labeling differs only in that biotin-tyramide is 
used as the substrate.
Neighborhood mapping of intracellular proteins began with in 
vivo BioID (Roux et al., 2012; Kim and Roux, 2016; Li et al., 2017) 
in which a promiscuous mutant form of the bacterial biotin ligase 
BirA (BirAR118G, henceforth referred to as BirA*) was used to trans-
fer biotin to nearby proteins (Choi-Rhee et al., 2004). This method 
was first used for mapping the neighborhood of lamin A, leading 
to the identification of a novel nuclear envelope protein (Roux 
et al., 2012). Subsequently, the method has been applied to many 
proteins of interest including insoluble, membrane-associated 
proteins in many eukaryotic cells (Beck et al., 2014; Chan et al., 
2014; Firat-Karalar et al., 2014; Chen et al., 2015; Lambert et al., 
2015). It has also been applied to whole plant systems (Khan 
et al., 2018).
APEX (proximity labeling with ascorbate peroxidase) has recently 
been developed as an alternative to in vivo BioID (Rhee et al., 2013). 
Initially APEX did not attempt to provide maps of interactors: the 
ascorbate peroxidase was expressed in a compartment-specific 
manner. To initiate labeling, cells are incubated with H2O2 and bio-
tin-phenol (a tyramide derivative) so the reaction can occur in the 
same manner as described for EMARS and SPPLAT. More recently, 
APEX has been expressed as a fusion protein enabling it to be used 
in a protein-specific manner to map the neighborhoods of micro-
proteins (Chu et al., 2017) and β-2 adrenergic receptor (Lobingier 
et al., 2017).
All of these methods harbor both strengths and weaknesses. The 
original in vivo BioID method required cells to be incubated with 50 
µM biotin for 18–24 h, during which time targets are continuously 
biotinylated. This approach is therefore not compatible with the 
proteomic study of dynamic processes. In contrast, HRP-based 
methods offer superior temporal resolution. Cells are typically incu-
bated with 500 µM of substrate for 30 min, before the addition of 
H2O2, for as little as 1 min. A concern with this approach, however, 
is that substrate labeling occurs wherever the fusion protein hap-
pens to be (i.e., both assembled at its ultimate destination, but also 
at all stages along the way to that destination following its transla-
tion), reducing its spatial resolution. Furthermore, HRP has been re-
ported to be more prone to unfolding and loss of activity than wild-
type BirA (Rees et al., 2015).
The caveats with published labeling methods and low copy 
numbers of kinetochore components relative to potential contami-
nants, led us to consider alternative approaches to study kineto-
chore maturation during mitosis. We noted that both wild-type 
(Fernandez-Suarez et al., 2008) and mutant versions of BirA (Choi-
Rhee et al., 2004) had previously been shown to be functional in 
vitro, albeit in restricted experimental conditions. We therefore 
explored the possibility that BioID labeling might be achievable in 
lysed cells. Remarkably, this appears to work extremely well. Our 
new in vitro method allows essentially instantaneous labeling of 
protein neighborhoods from the point of view of the cell cycle, 
because the cells are no longer living and are “frozen” at the point 
of lysis. To validate the method, we use in vitro BioID (ivBioID) to 
report initial descriptions of the protein neighborhoods of kineto-
chore protein CENP-A using a CENP-A:BirA* fusion protein under 
the control of an inducible promoter. Here we compare changes in 
the CENP-A neighborhood during interphase and mitosis. We re-
port the surprising finding that several CENP-A chaperones ap-
pear to be stably associated with both interphase and mitotic 
chromatin, an unexpected finding also recently reported by others 
(Zasadzinska et al., 2018).
RESULTS AND DISCUSSION
To identify proteins of the CENP-A neighborhood, we tagged CENP 
with BirAR118G (yielding BirA*-CENP-A) and generated a stable HeLa 
cell line in which BirA*-CENP-A was induced following doxycycline 
addition. Following a 24 h treatment with doxycycline plus 50 µM 
added biotin (Figure 1A), BirA*-CENP-A was detected at centro-
meres in both interphase and mitotic cells (Figure 1B, anti-myc). La-
beling with fluorescent streptavidin was consistent with centromeric 
staining and confirmed that the BirA* was functional (Figure 1B, 
streptavidin 488). In addition to the anticipated centromeric bioti-
nylation, a diffuse signal was detected throughout the nucleus, nu-
cleoli, and mitochondria (Figure 1B).
To determine the distance traveled by activated biotin before 
derivatizing a target protein we measured the dispersion of biotin 
from BirA*-CENP-A using correlative light and electron micros-
copy (CLEM). CENP-A is an excellent substrate for this because it 
is organized as a linear structure in the inner kinetochore plate. To 
determine the range of distances traveled by activated biotin fol-
lowing its release from BirA*-CENP-A, we performed the in vivo 
BioID protocol, then stained cells with Alexa Fluor 488 streptavidin 
conjugated to 5 nm colloidal gold. We then measured the distribu-
tion of gold around kinetochores (Figure 1, D–F). Overview images 
confirm that a mitotic cell of interest was identified and followed 
from LM (light microscopy) imaging through to EM (electron mi-
croscopy; Figure 1D). Higher-magnification images confirmed that 
individual chromosomes and their centromeres could also be fol-
lowed (Figure 1E, Zoom 1). Further examination of the images 
confirmed that centromeres visualized by LM correlated accurately 
with electron dense gold particles decorating linear “plates” in 
electron micrographs (Figure 1E, Zoom 2). The distribution of 
colloidal gold particles was measured using line scans, taken per-
pendicular to the long axis of the kinetochore plates (Figure 1Fi, 
red bars). High-magnification images confirmed that “in situ” gold 
particles (Figure 1Fi, bottom left panel) resembled free gold par-
ticles spotted onto Formvar-coated grids (Figure 1Fi, bottom right 
panel). The line-scan density profile revealed a remarkably narrow 
distribution of gold particles, with an overall span of ∼20 nm 
(Figure 1Fii). This correlates remarkably well with the thickness of 
kinetochore plates measured by thin-section electron microscopy 
(Rieder, 1982) and with previous estimates of the distances 
traveled by activated biotin (10–20 nm; Roux et al., 2012; 10 nm; 
Kim et al., 2014).
Because the half width of the gold distribution was only ∼10 nm, 
this experiment suggests that the activated biotin travels only a very 
limited distance before derivatization of a target protein. We would 
expect a sharp cutoff to this distribution outside the chromosome, 
because any labeled cytosolic proteins would presumably diffuse 
away from the site of labeling. In contrast, chromatin is relatively 
immobile, so we would have expected the labeling in subjacent 
chromatin to reflect the distance traveled by activated biotin. The 
fact that relatively little gold was found in the chromatin flanking the 
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FIGURE 1: Testing in vivo BioID using CENP-A. (A) Flowchart describing how HeLa tet-on cells, stable for the 
conditional expression of myc-BirA*CENP-A (BirA*–CENP-A), were cultured in media supplemented with doxycycline 
and 50 µm biotin for 24 h before processing for either microscopy or mass spectrometry. (B) Cells fixed and processed 
for immunofluorescence. The panels show representative examples of cells in interphase and mitosis probed with 
streptavidin 488 (green), anti-myc (red), and stained with DAPI (blue). (C) Immunoblot analysis of affinity-purified 
material from control (parental HeLa cell line) or BirA*–CENP-A expressing cells. Blots were probed with streptavidin 
800 IR LI-COR labels. (D–F) HeLa cells were seeded into CLEM dishes and cell culture media was supplemented with 
doxycycline and 50 µm biotin for 24 h. Cells were fixed, permeabilized, and probed with Alexa Fluor 488 dye–labeled 
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inner surface of the kinetochore strongly supports the assumption 
that BioID does indeed measure protein neighborhoods at the 
molecular level.
To characterize the specificity of the in vivo BioID method, cells 
expressing BirA*-CENP-A were subjected to the original BioID 
protocol (Materials and Methods) and then lysed and biotinylated 
proteins enriched by binding to streptavidin beads (Figure 1C). The 
affinity-purified material was then analyzed by mass spectrometry. In 
control experiments, cells not expressing BirA*-CENP-A were grown 
in the presence of 50 µm biotin, and affinity purifications performed 
in parallel. This in vivo analysis returned more than 500 hits, with 
CENP-A itself ranked at position 298, based on peptide score 
(Figure 1G and Supplemental Table 1). After subtracting proteins 
identified in the control pull downs, this experiment yielded a list of 
more than 300 proteins (Figure 1G and Supplemental Table 2) with 
CENP-A now ranked at position 109.
Although there were likely genuine proteins from the CENP-A 
neighborhood on this list, no other centromere proteins were de-
tected. Furthermore, given that CENP-A itself was ranked so far 
down the list, we concluded that attempting to identify other 
members of the CENP-A neighborhood by this approach would be 
unlikely to succeed. It was also evident that this approach (which 
requires labeling for 18–24 h in the presence of high biotin concen-
trations) could never allow us to discriminate between cell cycle– 
dependent interacting partners of CENP-A.
To address these problems of labeling specificity and temporal 
resolution, the method needed to be improved in two key areas: 
1) BirA*-specific labeling of target proteins over much shorter reac-
tion times and 2) better discrimination between specific and non-
specific biotinylation targets.
Indeed, the intracellular pool of free biotin is an issue with the 
published in vivo BioID protocol, as growing cells for less than 18–
24 h in medium supplemented with 50 µM biotin yielded low levels 
of BirA* labeling of target proteins (Roux et al., 2012). At physiologi-
cal levels (e.g., the concentration of biotin in fetal bovine serum 
[FBS]), the uptake of biotin into cells is relatively slow (Dakshinamurti 
and Chalifour, 1981; Chalifour and Dakshinamurti, 1982), and al-
though increasing the biotin concentration can increase its uptake 
(Chalifour and Dakshinamurti, 1982; Robinson et al., 1983), this 
improves only until transporter saturation is reached (Prasad et al., 
1998; Daberkow et al., 2003).
We speculated that one way to solve this problem and achieve 
rapid labeling of substrates with low backgrounds would be to con-
duct the biotinylation reaction in vitro, using permeabilized cells. To 
test whether such an in vitro system would be feasible, we designed 
a two-step protocol combining mild permeabilization of cells with 
incubation in a biotinylation reaction buffer (Figure 2A). Strikingly, 
we found that BirA* was active under these conditions (Figure 2, 
C–E), yielding biotinylation signals comparable to those obtained 
with a 24 h incubation in vivo (Figure 2B).
The in vitro biotinylation worked efficiently and reproducibly but 
was sensitive to the conditions used to permeabilize the cells. Ex-
traction of cells with SDS at concentrations of >0.01% appeared to 
abolish the reaction, and at 0.01% SDS, only occasional weak label-
ing was observed (Figure 2C). Of the conditions tested, brief extrac-
tion of cells with Triton X-100 at concentrations up to 0.1% appeared 
to be the most suitable for preserving BirA* functionality in the in 
vitro reaction (Figure 2C), and this concentration was used for all 
subsequent experiments.
We measured the efficiency of in vitro biotinylation (Figure 2D) 
by quantifying the fluorescence levels of streptavidin-Alexa 488 at 
centromeres following differing incubation periods with biotinyl-
ation buffer (Figure 2E). In control experiments, using the estab-
lished in vivo BioID protocol, BirA*-CENP-A produced robust levels 
of biotinylation at centromeres (Figure 2, B and E). Our in vitro pro-
tocol, which we refer to as in vitro BioID (ivBioID), was less efficient, 
but yielded clear centromeric biotinylation after as little as 2 min of 
incubation with biotinylation buffer. Only minor differences were ob-
served between biotinylation buffer incubations of 2, 5, and 10 min; 
however, longer incubations did result in greater levels of biotinyl-
ation (Figure 2, D and E). In control experiments, removing either 
biotin or ATP from the reaction buffer resulted in almost undetect-
able levels of biotinylation (Figure 2, D and E).
Clear visual evidence for the increased specificity of the in vitro 
biotinylation came from examining the results of in vitro biotinyl-
ation on mitotic chromosome spreads. Cells expressing BirA*-
CENP-A were arrested in mitosis with nocodazole, hypotonically 
swollen, and centrifuged onto glass slides. The ivBioID reaction was 
then performed, with labeling for 20 min. This procedure gave 
highly specific biotin labeling of the centromeres of mitotic chromo-
somes (Figure 3, A–C). In contrast, when cells were processed for 
the conventional in vivo BioID protocol and similar chromosome 
spreads were prepared, the biotin labeling was seen not only at 
centromeres, but also all along the chromosome arms (Figure 3, 
D–F). It is therefore clear that the ivBioID protocol can yield a more 
selective labeling of the neighborhood of the target protein.
Biotinylation with sub–cell cycle resolution
Having obtained evidence that ivBioID allows rapid biotinylation of 
substrates by BirA*, we next investigated whether this approach 
would also provide a more selective method for mapping protein 
neighborhoods. Our ultimate goal was to ask whether ivBioID could 
detect differences in the CENP-A neighborhood across the cell 
cycle. Indeed, immunofluorescence experiments confirmed that 
colloidal gold, conjugated to streptavidin (Molecular Probes), and imaged using LM to identify mitotic cells of interest. 
Cells were embedded in resin, sectioned, and imaged by transmission electron microscopy (TEM). (D) Low-magnification 
images showing the metaphase plate of mitotic cell chosen for CLEM. Images are DAPI (blue), regions of biotinylation 
(green), and the same cell reidentified by TEM. (E) Two progressive zooms of the boxed region shown in D, shown as 
LM merge (left), TEM (middle), and LM-TEM merge (overlay, right). Bottom panels (Zoom 2) show 9× magnifications of 
the white box in D. Top panels (Zoom 1) are a 3× magnification intermediate of part of the white box in D. Contrast-rich 
areas are visible corresponding to centromeres. The scale bar shows 100 nm (top) and 20 nm (bottom). (F) Pixel density 
analysis. Line scans (five to six per kinetochore—indicated in panel Fi, top) were taken through kinetochores, originating 
in the centromere and terminating in the cytoplasm, among kinetochore microtubules. The bottom left panel is an 
enlargement of the white box in Fi, showing a representative line scan passing through the kinetochore and terminating 
in the cytoplasm. The bottom right panel shows gold particles only, spotted onto a carbon film for comparison. Pixel 
densities were compiled and represented as a histogram (Fii). Predicted subcellular positions are noted beneath the 
histogram. Ncell = 2. Nkinetochore = 12. Bar = 20 nm. (G) Summary of the MS data returned for in vivo BirA*–CENP-A. 
Numbers in brackets represent the ranked position of CENP-A within the MS data, based on protein score.
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mitotic cells can also be labeled efficiently 
by the ivBioID protocol (Supplemental 
Figure 1).
For mass spectrometry analysis, we con-
ducted an ivBioID reaction on larger 
amounts of interphase and mitotic cells, af-
finity purified the biotinylated material using 
streptavidin beads, and analyzed the bound 
proteins by mass spectrometry (Figure 4A). 
Coomassie staining of the streptavidin pull 
downs revealed that samples prepared after 
ivBioID of mitotic cells contained less mate-
rial than those obtained from interphase 
cells (Figure 4B). Streptavidin labeling also 
suggested that levels of recovered protein 
were lower from mitotic than from inter-
phase cells.
Mass spectrometry analysis returned a to-
tal of 659 proteins from three repeats follow-
ing ivBioID of interphase cells and 506 pro-
teins from three repeats from ivBioID of 
mitotic cells. In control experiments, 484 and 
369 proteins were recovered from interphase 
or mitotic cells not expressing the BirA* fu-
sion protein (-doxycycline) and 455 and 355 
proteins were recovered from interphase or 
mitotic reactions performed in the absence 
of biotin. To identify the most specific ivBi-
oID–CENP-A interactors we firstly back-
ground-subtracted proteins identified in con-
trol experiments; secondly, only considered 
hits present in at least two of the three re-
peats; and lastly, removed all proteins whose 
abundance score in the mass spectrometer 
fell below a minimum confidence threshold. 
The final list returned 20 and 9 proteins for 
the interphase and mitotic samples, respec-
tively (Figure 5A). Importantly, both lists con-
tained CENP-A, CENP-B, and CENP-C.
Validation of the CENP-A 
neighborhood in interphase 
and mitosis
Combining the CENP-A data from both in-
terphase and mitotic cells over the three 
experiments yielded a comprehensive list of 
proteins proximal to CENP-A as determined 
by this method (Figure 5A). Importantly, 
most of these proteins had been previously 
shown in other studies to be associated with 
CENP-C in chromatin or in its preassembly 
complexes.
From the list of CENP-A interphase inter-
actors, two groups of proteins became ap-
parent (Figure 5B). The first is found in the 
interphase centromere complex (ICEN)—
the first published set of CENP-A–associ-
ated proteins, which were identified by the 
Yoda lab. The ICEN complex was a cohort of 
40 proteins purified from HeLa cells follow-
ing micrococcal nuclease digestion of chro-
matin and immunoprecipitation with a 
FIGURE 2: Rapid in vitro biotinylation (ivBioID) of CENP-A. (A) Flowchart of ivBioID method. 
(B) Immunofluorescence of in vivo prepared BirA*–CENP-A cells. In panels B and E, 24 h+ 
represents an in vivo BioID sample extracted with 0.1% Triton X-100 before fixation. Panels 
t = 0 represent a sample with no biotin incubation. (C) Summary of results of cells prepared 
using the protocol described in A, under a variety of detergent extraction conditions. (D) Immuno-
fluorescence of ivBioID–CENP-A prepared cells. Cells were permeabilized with 0.1% Triton X-100 
extraction for 2 min. Several biotinylation buffer incubation time points were tested. Cells were 
fixed and processed for IF as standard and labeled with streptavidin 488 (green) or anti-myc (red). 
In panels D and E, 15 min* represents cells incubated with biotin buffer lacking ATP. Bar = 5 µm; 
Zoom bar = 1 µm. (E) Bar graph showing quantification of centromeric immunofluorescence from 
samples prepared as for B and D. Bars show the mean fluorescence of streptavidin 488 normalized 
to myc fluorescence. Ncell = 20. Ncentromere = 200.
Volume 30 May 15, 2019 In vitro BioID | 1319 
monoclonal antibody to CENP-A (Ando et al., 2002; Obuse et al., 
2004; Izuta et al., 2006). Remarkably, nine of the 20 interphase 
ivBioID hits are found in the list of ICEN proteins, including CENP-A 
FIGURE 3: Chromosome spreads from both in vivo and in vitro 
prepared samples. Qualitative samples were prepared for comparison 
of in vivo and in vitro BioID samples. Experimental conditions include 
cells not expressing BirA*–CENP-A and not treated with biotin (A and 
D); cells expressing BirA*–CENP-A but not treated with biotin (B and 
E); cells expressing BirA*–CENP-A and treated with biotin (C and F). 
All samples were fixed and probed with DAPI, anti-myc (red), and 
streptavidin 488 (green). Zooms are of the white boxed region in 
“MERGE.” Bar = 5 and 1 µm.
itself. The other eight proteins are CENP-B, CENP-C, PHIP, SUPT16H, 
DDB1, SRRT, HSPA8, and FIB.
The appearance of CENP-C was expected, because this protein 
has been shown to bind directly to CENP-A (Dunleavy et al., 2009; 
Foltz et al., 2009; Carroll et al., 2010; Guo et al., 2017). Although 
CENP-C is not strictly dependent on CENP-A for localization to 
kinetochores in Drosophila (Erhardt et al., 2008) or in chicken DT40 
cells (Samejima et al., 2015), it does appear to require CENP-A for 
kinetochore localization in human cells and in Caenorhabditis elegans 
(Oegema et al., 2001; Liu et al., 2006). Similarly, the interaction be-
tween CENP-B and CENP-A nucleosomes at the centromere is very 
well characterized, although the role of CENP-B remains under inten-
sive study (Fachinetti et al., 2015; Hoffmann et al., 2016). The role of 
the other ICEN proteins at centromeres remains to be determined.
A second group of six proteins observed in the list of interphase 
ivBioID hits is found in the CENP-A prenucleosomal complex. These 
are HJURP, NPM1, DDX17, EIF4A1, XRCC5, and DDX3X. This com-
plex is involved in CENP-A deposition. Indeed, HJURP is the chap-
erone that inserts CENP-A into chromatin. The CENP-A prenucleo-
somal complex presumably exists in both interphase and mitosis so 
that cells are ready for CENP-A deposition at centromeres specifi-
cally in a window during mitotic exit when CDK1 activity drops (Jan-
sen et al., 2007; Silva et al., 2012). It was surprising that this complex 
was detected by ivBioID, because the protocol involves a detergent 
permeabilization step that would be expected to wash away soluble 
proteins and protein complexes. Our analysis thus suggests that the 
CENP-A prenucleosomal complex must be relatively stably en-
gaged either at centromeres or at other sites on chromatin both in 
interphase and during mitosis. This unexpected observation has re-
cently been confirmed by others (Zasadzinska et al., 2018).
Of the four remaining proteins found by interphase ivBioID with 
CENP-A, three were previously reported in immunoprecipitation 
studies for interactions with CENP-A. NOL8, PARP1, and PRKDC 
were either found by using CENP-A or themselves as the bait pro-
tein (Saxena et al., 2002; Shuaib et al., 2010; De Antoni et al., 2012; 
Hein et al., 2015). Remarkably, the only interphase “hit” protein not 
previously recovered in a complex with CENP-A is Aurora B kinase. 
However, Aurora B and Aurora A can both phosphorylate CENP-A 
on serine 7 (Zeitlin et al., 2001; Kunitoku et al., 2003; Boeckmann 
et al., 2013). This phosphorylation has been reported to have 
an unexpected role in regulating cytokinesis (Zeitlin et al., 2001) 
and also to be involved in localization of the CPC to centromeres 
(Kunitoku et al., 2003). Surprisingly, in our study, biotinylated Aurora 
B was observed in the absence of its three auxiliary CPC subunits 
INCENP, Survivin, and Borealin.
The list of mitotic proteins in the CENP-A neighborhood was 
much shorter. Aside from CENP-B and CENP-C we recovered two 
members of the prenucleosomal complex (DDX5 and HNRNPC). 
Again, it was unexpected and interesting that two members of the 
CENP-A prenucleosomal complex would be associated with mitotic 
CENP-A. Among the others, PBH2 was reported to be involved in 
kinetochore assembly and protecting sister chromatid cohesion 
(Takata et al., 2007; Lee et al., 2011), but has not been reported to be 
linked with CENP-A. The other three proteins, RPL8 (a ribosomal pro-
tein), RBM39 (a splicing factor), and GTPBP4 (a nucleolar GTP-binding 
protein), do not have obvious links to kinetochores or CENP-A and 
determination of their link to CENP-A requires further investigation.
Gene ontology analysis of hits
To better understand the CENP-A neighborhood during interphase 
and mitosis, gene ontology analysis was carried out on the two hit 
lists. The biological functions of the proteins in both of these lists 
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(Figure 6) show a large crossover between the functions of the pro-
teins found in both interphase and mitosis, the largest of these 
groups being kinetochore assembly. This was expected, particularly 
when considering that a greater percentage of the mitotic hits are 
seen to be involved in this process. Also prominent were other chro-
matin-related categories, including nucleosome organization, ATP-
dependent chromatin remodeling, sister chromatid cohesion, and 
chromosome organization.
Looking more generally at the cellular components in which the 
proteins fall (Figure 6B), all our proteins fell into only four categories: 
nuclear pericentric heterochromatin, granular components, centro-
meric protein, and nuclear lumen. All but the granular components 
are nuclear/chromatin specific. The association with the granular com-
ponent of the nucleolus is less obvious. Indeed, some of these pro-
teins, which are extremely abundant in cells, could be contaminants.
We can conclude from this analysis that the ivBioID method 
generates lists of enriched proteins that are relevant for CENP-A– 
related activities. Thus, the method appears to have high specificity 
and to be capable of detecting relatively nonabundant components 
of insoluble cellular structures.
Perspective
The ivBioID method reveals information about the CENP-A neigh-
borhood that differs from interaction maps reported by classical 
methods such as two hybrid screens and tandem affinity pull-down 
screens. Thus, ivBioID provides an additional, orthogonal method 
for the exploration of protein relationships. The method revealed 
a majority of proteins that were previously known to interact di-
rectly with CENP-A, including CENP-C, CENP-B, and HJURP; it 
also offered insights into the changes in the CENP-A environment 
at interphase and mitosis. Interestingly, despite the stability of 
CENP-A nucleosomes in vivo (Bodor et al., 2013), its environment 
is characterized by dynamic chromatin, as shown by the presence 
of proteins specific for chromatin remodeling as well as CENP-A 
nucleosome assembly.
Because the ivBioID method works with cells that have been har-
vested and permeabilized and are no longer physiologically active, 
it offers what is effectively “instantaneous” time resolution of cellular 
processes. Thus, if cultures can be synchronized or sorted, this 
method should offer a useful approach to determining differences 
in protein neighborhoods in cells grown under normal conditions 
FIGURE 4: Production of samples for ivBioID analysis of CENP-A. (A) Comparison of original in vivo BioID (top) and in 
vitro BioID (bottom) methodologies showing addition of the permeabilization step and post lysis biotinylation. 
(B) Coomassie blue stain gel of samples submitted for MS showing controls and hit samples. (C) Western blot of 
samples submitted for MS showing controls and hit samples. Biotinylation can be seen in the bottom panel, and 
anti-myc–BirA*–CENP-A can be seen in the top panel.
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without stresses imposed by exposure to extended and high concen-
trations of biotin or transient shock with H2O2. Furthermore, because 
the bulk of soluble proteins are removed by the detergent extraction, 
the method exhibits a remarkably low background, provided that the 
goal is to look at relatively stable structural interactions.
Since these experiments were performed, a new method for 
in vivo biotin labeling of protein neighborhoods known as “Tur-
boID” has been published (Branon et al., 2018). The authors 
used directed evolution to produce a highly mutated BirA that 
can biotinylate target proteins in vivo in HEK 293T cells in as little 
as 10 min and also in living Drosophila melanogaster and C. el-
egans. TurboID clearly addresses a number of the difficulties with 
previous in vivo BioID methods, and provides a powerful comple-
ment to the in vitro method described here. TurboID provides 
much longer lists of potential neighbors (which can be a strength 
or a weakness) and should be able to detect weak or transient 
interactions. In contrast, ivBioID provides lower background, 
much shorter hit lists, can analyze changes over even finer time 
intervals (e.g., a minute or even less in highly time-sensitive pro-
cesses like mitosis), and will presumably detect primarily stable 
interactions (which may be easier to validate than weak or tran-
sient interactions). Furthermore, it should be useful in any cell 
type or organism, independent of the biotin transport or endog-
enous pools. Together, classic BioID (Roux et al., 2012) and these 
new methods are opening up powerful new approaches to ana-
lyzing protein proximities in cells.
MATERIALS AND METHODS
Cell culture
HeLa cells were maintained in DMEM containing 10% FBS and 
100U/ml penicillin/streptomycin at 37°C and 5% CO2.
For preparation of stable cell lines, CENP-A was amplified by PCR 
from HeLa cDNA and cloned into pcDNA3.1-mycBioID vector (Ad-
dgene) using Not1 and Afl2 restriction sites. Myc-BirA(R118G)–
CENP-A was amplified by PCR from pcDNA3.1-mycBioID–CENP-A 
vector and cloned into a tet-on 3G inducible expression vector 
(Clontech). Tet-On 3G vectors were cotransfected, with a linear resis-
tance gene, into HeLa cells expressing the tetracycline-regulated 
transactivator (Clontech), using GeneJuice (Novagen). Stable cell 
lines were enriched using antibiotic selection for 7–14 d. Surviving 
clones were expanded and screened for the stable, inducible expres-
sion of Myc-BirA(R118G)–CENP-A (otherwise known as BirA*–CENP-
A) by immunofluorescence microscopy. Expression of the fusion 
protein was observed in >90% of cells in the selected culture.
Indirect immunofluorescence microscopy
Cells were fixed in 4% paraformaldehyde (PFA) and processed as 
previously described (Booth et al., 2014). The primary antibodies or 
fluorescent labels used were as follows: anti–α-tubulin antibody 
(B512; Sigma); anti-myc Alexa Fluor 555 conjugate (Millipore); strep-
tavidin Alexa Fluor 488 conjugate (Life Technologies); and anti–
CENP-C. Three-dimensional data sets were acquired using a cooled 
CCD camera (CH350; Photometrics) on a wide-field microscope 
(DeltaVision Spectris; Applied Precision) with a NA 1.4 Plan 
Apochromat lens. The data sets were deconvolved with softWoRx 
(Applied Precision). Three-dimensional data sets were converted to 
Quick Projections in softWoRx, exported as TIFF files, and imported 
into Adobe Photoshop or Adobe Illustrator for final presentation.
CLEM
The CLEM processing method was adapted from previously es-
tablished protocols (Booth et al., 2011, 2013, 2014). Briefly, HeLa 
cells conditionally expressing BirA*–CENP-A were seeded onto 
glass-bottomed gridded dishes (MatTek Corporation) in medium 
supplemented with biotin (50 µM) and doxycycline (1 µg/ml). Fol-
lowing a 24 h expression period, cells were fixed using a mixture 
of glutaraldehyde and paraformaldehyde for 1 h. Next, cells were 
permeabilized, blocked in 3% bovine serum albumin, and probed 
with Alexa Fluor 488 dye–labeled colloidal gold, conjugated to 
streptavidin (Molecular Probes), for 1 h. Samples were washed (in 
phosphate-buffered saline [PBS] containing Hoechst) and cells of 
interest identified using a wide-field epifluorescence microscope 
(DeltaVision RT; Applied Precision). Cells with centromere label-
ing were located and their position mapped using transmitted 
light to visualize reference coordinates. Cells were then postfixed 
for 20 min in 1.5% PFA, before osmication (0.5% osmium tetrox-
ide in PBS), dehydrated (using a graded series of ethanol), and 
FIGURE 5: Analysis of the CENP-A neighborhood in interphase and 
mitosis using ivBioID. (A) Venn diagram showing the final filtered hit 
lists for interphase (green) and mitotic (yellow) samples and how they 
overlap with one another. Interphase hits labeled with * were also 
observed in the mitotic hit list but were under the confidence level. 
The overlap in red shows those proteins seen in both interphase and 
mitotic lists. (B) Proteins observed in the interphase ivBioID final hit 
list (green) show overlap with known CENP-A interacting proteins. 
The bulk of the proteins detected by ivBioID correspond to proteins 
previously found in the ICEN complex (yellow overlap; Ando et al., 
2002; Obuse et al., 2004; Izuta et al., 2006) and the CENP-A 
prenucleosomal complex (blue overlap; Foltz et al., 2006). The other 
proteins not detected in our analysis but found in the original 
descriptions of the ICEN complex (orange) and CENP-A 
prenucleosomal complex (pale yellow) are also shown. Hits labeled 
with + were previously found in pull downs using either CENP-A or 
themselves as the target.
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embedded in resin. Once cured, ultrasmall resin blocks (50 µm2) 
were fine trimmed and serial sections (85 nm thickness) taken at 
areas corresponding to previously chosen coordinate positions. 
Cells were visualized with a Phillips CM120 BioTwin transmission 
electron microscope (FEI) and micrographs acquired using a 
Gatan Orius CCD camera (Gatan).
The appropriate Z position correlative light/EM images of a cell 
were concatenated using ImageJ and then analyzed and overlaid 
using Photoshop Elements 6 (Adobe).
Centromeric gold labeling and pixel density analysis
Electron micrographs containing mitotic chromosomes were 
selected for analysis of gold particles at the centromere. The pixel 
density of a 1 µm region of interest (ROI) was measured using the 
raw data from the “plot profile” function of ImageJ. For unbiased 
consistency, the 1 µm ROI always started within the chromosome 
body and finished in the cytoplasm, with the halfway point lying at 
the region most dense with gold label. Approximately 150 individ-
ual pixel density measurements were taken within each 1 µm re-
gion. The data were plotted as a line-scan profile, with each data 
point representing the mean of 6 × 1 µm regions of interest per 
centromere.
In vivo BioID method
This was based on the method described by Roux et al. (2012). 
Cells were seeded into 4 × 10 cm dishes and incubated for 24 h in 
complete media supplemented with 1 µg/ml doxycycline and 
50 µM biotin. Cells were trypsinized, centrifuged, and resuspended 
in 1 ml lysis buffer at 25°C (50 mM Tris, pH 7.4, 500 mM NaCl, 0.4% 
SDS, 5 mM EDTA, 1 mM dithiothreitol [DTT], and 1× complete 
protease inhibitor [Roche]), and sonicated. Triton X-100 was added 
to 2% final concentration. After further sonication, an equal vol-
ume of 4°C 50 mM Tris (pH 7.4) was added before additional soni-
cation (subsequent steps at 4°C) and centrifugation at 16,000 × g. 
Supernatants were incubated with 100 µl Dynabeads (MyOne 
steptavadin C1; Invitrogen) for 1 h at RT. Beads were collected and 
washed twice for 8 min at 25°C (all subsequent steps at 25°C) in 
1 ml wash buffer 1 (2% SDS in dH2O). This was repeated once with 
wash buffer 2 (0.1% deoxycholate, 1% Triton X-100, 500 mM NaCl, 
1 mM EDTA, and 50 mM HEPES, pH 7.5), once with wash buffer 
3 (250 mM LiCl, 0.5% NP-40, 0.5% deoxycholate, 1 mM EDTA, and 
10 mM Tris, pH 8.1), and twice with wash buffer 4 (50 mM Tris, 
pH 7.4, and 50 mM NaCl). Ten percent of the sample was reserved 
for Western blot analysis. Bound proteins were eluted from the 
magnetic beads with 50 µl of Laemmli SDS sample buffer saturated 
FIGURE 6: GO enrichment analysis of interphase and mitotic ivBioID hit lists. GO analysis using the hit lists obtained 
from the MS reveals enrichment for a subset of biological processes and cellular components. Both sets of samples 
were run through the g-Profiler toolkit (Reimand et al., 2016) and the significant terms (P < 0.01) for each sample were 
recorded (Supplemental Table 3). We calculate log2 enrichment for each GO term using the fraction of these terms per 
sample against the ratio of these terms in the database used by g-Profiler. (A) Biological processes in which the proteins 
found in the hit lists are enriched. (B) Cellular process in which the proteins found in the hit lists are enriched.
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with biotin at 98°C. Eluent (90%) was submitted for mass spec-
trometry analysis.
In vitro BioID method
Cells were seeded into 10 cm dishes for asynchronous cells and 
15 cm dishes for mitotic cells and incubated for 24 h in complete 
medium supplemented with 1 µg/ml doxycycline. For mitotic 
samples cells were treated with nocodozole (100 ng/ml) for 13 h. 
Mitotic cells were enriched via mitotic shake off. Asynchronous 
cells were collected via trypsinization. Cells were centrifuged and 
resuspended in 0.1% Triton X-100 in PBS for 1.5 min at 37°C. Sam-
ples were centrifuged and washed once in warmed PBS before 
incubation in biotinylation buffer (40 mM Tris:HCl, pH 8.0, 5 mM 
MgCl2, 3 mM ATP, 100 µM KCl, 50 µM biotin) for 15 min at 37°C. 
Cells were centrifuged and washed once in warmed PBS, before 
resuspension in 100 µl solubilization buffer at 25°C (50 mM 
triethanolamine:HCl, pH 7.4, 100 mM NaCl, 2 mM K-EDTA, pH 7.4, 
0.4% SDS, 2 mM β-mercaptoethanol, 0.1 mM phenylmethylsulfo-
nyl fluoride, 0.1% trasylol, 1 µg/ml chymostatin, leupeptin, anti-
pain, pepstatin [CLAP]), and sonicated at 4°C. Samples were then 
centrifuged at 16,000 × g. Supernatants were transferred to clean 
tubes before addition of 400 µl RIPA buffer (50 mM Tris:HCl, pH 
8.0, 150 mM NaCl, 1% Na deoxycholate, 0.1% SDS, 1× cOmplete 
ULTRA protease inhibitor; Roche) and subsequent incubation with 
100 µl Dynabeads (MyOne steptavadin C1; Invitrogen) for 18 h at 
4°C. Beads were collected and washed twice for 5 min at 25°C 
rotating (all subsequent steps at 25°C) in 1 ml PBS containing 500 
mM NaCl. Subsequently two washes were performed in 1 ml PBS 
containing 250 mM NaCl, followed by two washes in 1 ml PBS and 
a final wash in 1 ml mass spectrometry grade H2O. Bound proteins 
were eluted from the magnetic beads with 50 µl of Laemmli SDS 
sample buffer saturated with biotin at 95°C. Ten percent of the 
sample was reserved for Western blot analysis. Ninety percent of 
the eluent was submitted for mass spectrometry analysis.
Immunoblotting analysis
For immunoblotting, 10% of the total eluent, purified for mass spec-
trometry, was loaded onto polyacrylamide gels. SDS–PAGE and im-
munoblotting were performed following standard procedures. The 
antibodies or fluorescent labels used were as follows: anti-myc 9E10 
(Abcam); IRDye 800CW streptavidin (LI-COR); anti-mouse IRDye 
680CW (LI-COR).
Mass spectrometry analysis
Protein samples were run on gels (NuPAGE Novex 4–12% Bis-Tris 
gel; Life Technologies, UK), in NuPAGE buffer (MES) and visualized 
using Imperial protein stain (Life Technologies, UK). The stained gel 
bands were excised and destained with 50 mM ammonium bicar-
bonate (Sigma Aldrich, UK) and 100% (vol/vol) acetonitrile (Sigma 
Aldrich, UK), and proteins were digested with trypsin, as previously 
described (Shevchenko et al., 1996). Briefly, proteins were reduced 
in 10 mM DTT (Sigma Aldrich, UK) for 30 min at 37°C and alkylated 
in 55 mM iodoacetamide (Sigma Aldrich, UK) for 20 min at ambient 
temperature in the dark. They were then digested overnight at 37°C 
with 13 ng µl−1 trypsin (Pierce, UK).
Following digestion, samples were diluted with equal volumes 
of 0.1% trifluoroacetic acid (TFA) and spun onto StageTips as 
described by Rappsilber et al. (2003). Peptides were eluted in 40 µl 
of 80% acetonitrile in 0.1% TFA and concentrated down to 1 µl by 
vacuum centrifugation (Concentrator 5301; Eppendorf, UK). Sam-
ples were then prepared for liquid chromatography–mass spec-
trometry (LC-MS)/MS analysis by diluting them to 6 µl with 0.1% 
TFA. LC-MS analyses were performed on a Q Exactive mass spec-
trometer (Thermo Fisher Scientific, UK) coupled online, to an Ulti-
mate 3000 RSLCnano System (Dionex; Thermo Fisher Scientific, 
UK). Peptides were separated on a 50 cm EASY-Spray column 
(Thermo Fisher Scientific, UK) assembled in an EASY-Spray source 
(Thermo Fisher Scientific, UK) and operated at 50°C. Mobile phase 
A consisted of 0.1% formic acid in water, whereas mobile phase B 
consisted of 80% acetonitrile and 0.1% formic acid. Peptides were 
loaded onto the column at a constant flow rate of 0.3 µl min−1 and 
eluted at a flow rate of 0.2 µl min−1 according to the following gradi-
ent: 2–40% mobile phase B in 120 min, then to 95% in 11 min. 
Fourier transform mass spectrometry spectra were recorded at 
70,000 resolution (scan range 350–1400 m/z) and the 10 most in-
tense peaks with charge ≥2 of the MS scan were selected with an 
isolation window of 2.0 Thomson for MS2 (filling 1.0E6 ions for MS 
scan, 5.0E4 ions for MS2, maximum fill time 60 ms, dynamic exclu-
sion for 50 s). Fragmentation was performed by employing HCD 
(Olsen et al., 2007) with normalized collision energy of 27.
The MaxQuant software platform (Cox and Mann, 2008) 
version 1.5.2.8 was used to process raw files and searches were 
conducted against Homo sapiens complete/reference proteome 
set of Uniprot database (released in March 2017), using the 
Andromeda search engine (Cox et al., 2011). For the first search, 
peptide tolerance was set to 20 ppm, whereas for the main 
search peptide tolerance was set to 4.5 ppm. Isotope mass toler-
ance was 2 ppm and the maximum charge was 7. A maximum of 
two missed cleavages was allowed. Carbamidomethylation of 
cysteine was set as a fixed modification. Oxidation of methionine 
and acetylation of the N-terminal were set as variable modifica-
tions. Peptide and protein identifications were filtered to 1% 
false discovery rate.
Filtering and analysis of hits
The following approach was used to reduce the background and 
obtain hits lists. First, the three repeats were combined, yielding one 
list for each experimental condition. Next those lists were filtered, 
keeping only proteins for which at least two independent peptides 
had been identified. Subsequently, proteins found in either of the 
control lists—1) cells not expressing BirA*–CENP-A and 2) cells that 
had not been exposed to biotin—were subtracted from the corre-
sponding master list of interphase or mitotic hits. The data were 
further filtered by removing proteins that were not observed in at 
least two of the repeats. Finally, a confidence level based on pep-
tide score (a comparison of the observed spectrum for each peptide 
with the theoretically calculated spectrum for that peptide; Cox and 
Mann, 2008) was applied to the interphase and mitotic hit lists. Pro-
teins with a score below 1 were removed, thereby yielding the final 
hit lists for both conditions.
Bioinformatics and gene ontology analysis
Final hit lists from both conditions were run through the g-Profiler 
toolkit (Reimand et al., 2016) and the significant terms (P < 0.01) for 
each sample were recorded in the output. This was then used to 
calculate log2 enrichment for each gene ontology (GO) term using 
the fraction of these terms per sample against the ratio of these 
terms in the database used by g-Profiler.
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